The Quality Policy is defined by production of quality products ensured by adhering to Good Manufacturing Practices (GMP) which constitute international set of guidelines for the manufacture of drugs and medical devices. This ensures risk mitigation with reference to manufacturing, packaging, testing, labelling, distributing etc. The protocols are largely concerned with parameters such as drug quality, safety, efficacy and potency.
The Quality Policy is followed to the last letter by one and all in the organization.
Aegonpharma meticulously follows the GMP guidelines as those are adopted by over 100 countries either in the form of regulations or Directives or Guides or Codes.
The procurement of material for production has to be from a reputed, approved, renowned and standardized vendor that is our first and foremost step that starts right with material planning. The stability and the quality of the products is monitored during the shelf life until the release of finished goods for sale and expiry of the product.
The high quality of the products is maintained by operating in total compliance with the GMP norms set by the WHO. Adequate, well qualified technical team, calibrated equipment and well-laid out Standard Operating Procedures (SOPs) are responsible for following the international norms.
The products are subjected to a series of tests before, during and post production. The environment and utilities are continuously monitored on a real-time basis.
Quality Management & Assurance
We at Aegonpharma validate Total Quality Management by maintaining high safety standards and application of environment friendly and clean processes.
By adapting to the latest technological innovations, our quality control Labs have been fortified with the latest equipment offering excellence at each stage of processing. Quality of the product is never compromised irrespective of the domestic and overseas markets, thus ensuring uniform results all throughout.